Page 5 - Flipbook
P. 5

DISCLOSURES









             • Financial interests: Honoraria (Institution) : Pfizer, BMS, Ipsen, Roche, MSD,

             Merck, Novartis, AstraZeneca, Roche, Amgen, Astellas, Exelixis, EISAI.







             • ESMO, EAU, AFU  - Renal Cell Carcinoma Guidelines Panel member







             • GETUG Board
   1   2   3   4   5   6   7   8   9   10